ATE99298T1 - 1,4,8-triazacyclotridecan-derivate mit prolylendopeptidase-hemmender wirkung. - Google Patents

1,4,8-triazacyclotridecan-derivate mit prolylendopeptidase-hemmender wirkung.

Info

Publication number
ATE99298T1
ATE99298T1 AT91104163T AT91104163T ATE99298T1 AT E99298 T1 ATE99298 T1 AT E99298T1 AT 91104163 T AT91104163 T AT 91104163T AT 91104163 T AT91104163 T AT 91104163T AT E99298 T1 ATE99298 T1 AT E99298T1
Authority
AT
Austria
Prior art keywords
triazacyclotridecan
prolylene
derivatives
inhibitor activity
endopeptidase inhibitor
Prior art date
Application number
AT91104163T
Other languages
English (en)
Inventor
Toda Soichiro
Oki Toshikazu
Hamagishi Yasutaro
Tomita Koji
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE99298T1 publication Critical patent/ATE99298T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AT91104163T 1990-03-22 1991-03-18 1,4,8-triazacyclotridecan-derivate mit prolylendopeptidase-hemmender wirkung. ATE99298T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/497,292 US4999349A (en) 1990-03-22 1990-03-22 BU-4164E - A and B, prolyl endopeptidase inhibitors

Publications (1)

Publication Number Publication Date
ATE99298T1 true ATE99298T1 (de) 1994-01-15

Family

ID=23976256

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91104163T ATE99298T1 (de) 1990-03-22 1991-03-18 1,4,8-triazacyclotridecan-derivate mit prolylendopeptidase-hemmender wirkung.

Country Status (7)

Country Link
US (1) US4999349A (de)
EP (1) EP0451547B1 (de)
JP (1) JPH06339390A (de)
AT (1) ATE99298T1 (de)
CA (1) CA2038509A1 (de)
DE (1) DE69100865D1 (de)
DK (1) DK0451547T3 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073549A (en) * 1990-03-22 1991-12-17 Bristol-Myers Squibb Company BU-4164E - A and B, prolyl endopeptidase inhibitors and their methods of use
GB9024208D0 (en) * 1990-11-07 1990-12-19 Salutar Inc Compounds
US5449750A (en) * 1991-06-20 1995-09-12 Snow Brand Milk Products Co., Ltd. Prolyl endopeptidase inhibitors SNA-115 and SNA-115T, and process for the production and productive strain thereof
AU7814301A (en) * 2000-08-02 2002-02-13 Slil Biomedical Corp Cyclic polyamine compounds for cancer therapy
US20030072715A1 (en) * 2000-08-02 2003-04-17 Benjamin Frydman Cyclic polyamine compounds for cancer therapy
ATE462432T1 (de) 2003-05-05 2010-04-15 Probiodrug Ag Glutaminylcyclase-hemmer
JP2007509898A (ja) 2003-11-03 2007-04-19 プロビオドルグ エージー 神経障害治療に有用な組合せ
KR101099206B1 (ko) 2004-02-05 2011-12-27 프로비오드룩 아게 신규한 글루타미닐 시클라제 저해제
JP5379692B2 (ja) 2006-11-09 2013-12-25 プロビオドルグ エージー 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体
EP2091948B1 (de) 2006-11-30 2012-04-18 Probiodrug AG Neue inhibitoren von glutaminylcyclase
CA2679446C (en) 2007-03-01 2016-05-17 Probiodrug Ag New use of glutaminyl cyclase inhibitors
US9656991B2 (en) 2007-04-18 2017-05-23 Probiodrug Ag Inhibitors of glutaminyl cyclase
US8524654B2 (en) * 2007-05-21 2013-09-03 The Uab Research Foundation Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation
BR112012008346B1 (pt) 2009-09-11 2021-12-21 Vivoryon Therapeutics N.V. Derivados heterocíclicos, seu processo de preparação, e composição farmacêutica
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
DK2545047T3 (da) 2010-03-10 2014-07-28 Probiodrug Ag Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5)
EP2560953B1 (de) 2010-04-21 2016-01-06 Probiodrug AG Hemmer der glutaminylzyklase
WO2012123563A1 (en) 2011-03-16 2012-09-20 Probiodrug Ag Benz imidazole derivatives as inhibitors of glutaminyl cyclase
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6137764A (ja) * 1984-07-31 1986-02-22 Suntory Ltd 抗プロリルエンドペプチダ−ゼ活性を有する新規生理活性化合物
JPH0623190B2 (ja) * 1985-04-16 1994-03-30 サントリー株式会社 インヒビタ−活性を有するｎ−アシルピロリジン誘導体及びその製法並びに用途
EP0201743B1 (de) * 1985-04-16 1992-04-01 Suntory Limited Dipeptid-Derivate von Fettsäure, Verfahren zu ihrer Herstellung, Heilmittel, das sie enthält und Anwendung
US4898940A (en) * 1985-08-30 1990-02-06 Bristol-Myers Company Peptide antibiotics
JPH0764834B2 (ja) * 1985-11-29 1995-07-12 サントリー株式会社 プロリルエンドペプチダーゼ阻害活性を有する新規ピロリジンアミド誘導体およびその製法並びに用途
CA1320734C (en) * 1986-02-04 1993-07-27 Suntory Limited Pyrrolidineamide derivative of acylamino acid and pharmaceutical composition containing the same
JPH08806B2 (ja) * 1986-11-18 1996-01-10 サントリー株式会社 プロリルエンドペプチダ−ゼ阻害作用を有する新規ピロリジンアミド誘導体
EP0461677B1 (de) * 1987-02-23 1997-04-16 Ono Pharmaceutical Co., Ltd. Thiazolidin-Derivate
US4857524A (en) * 1987-08-08 1989-08-15 Kissei Pharmaceutical Co., Ltd. Thiazolidine compounds and therapeutic method

Also Published As

Publication number Publication date
DK0451547T3 (da) 1993-12-29
DE69100865D1 (de) 1994-02-10
CA2038509A1 (en) 1991-09-23
JPH06339390A (ja) 1994-12-13
US4999349A (en) 1991-03-12
EP0451547A1 (de) 1991-10-16
EP0451547B1 (de) 1993-12-29

Similar Documents

Publication Publication Date Title
ATE99298T1 (de) 1,4,8-triazacyclotridecan-derivate mit prolylendopeptidase-hemmender wirkung.
AU1642795A (en) Substituted pyridylpyrazoles
EP0245518A4 (de) Isoflavon-abkömmlinge, salze dazu sowie onkostatische und immunsuppressive mittel.
DK0572166T3 (da) Hidtil ukendte 7beta-substitueret-4-aza-5beta-androstan-3-oner som 5beta-reduktaseinhibitorer
DK0706393T3 (da) Immun-undertrykkende og antiallergiske forbindelser, f.eks. N-(3-oxohexanoyl)homoserin-lacton
ATE267164T1 (de) 9-(substituiertes glycyl)amido-6-(substituiert)-5-hydroxy-6-deoxy etracycline
FI954979A7 (fi) Kemoherkistävinä aineina käytettävät 10,11-metanodibentsosuberaanijohdannaiset
DK0582829T3 (da) 9-(Substitueret glycyl)amido-6-demethyl-6-deoxytetracycliner som antibiotiske midler
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
ATE338744T1 (de) Hydrazonderivate
FI930772L (fi) Hydroxiureaderivat som saenker glugosnivao i blodet
FI962022A7 (fi) 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraali sina aineina
NO944406L (no) Nye 7 e inhibitorer
PT843679E (pt) Derivados da1-(piperidinil 1,2-disubstituido)-(4-imidazole fundido)-piperidina
KR950704257A (ko) 매트릭스 메탈로프로테이나제 억제제로서의 카보스티릴 유도체(Carbostyril derivatives as matrix metalloproteinases inhibitors)
DK0747392T3 (da) Dobbeltvirkende inhibitorer indeholdende 1,2-diazepiner
FI962021L (fi) 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
ATE142226T1 (de) Balhimycin-abgeleitete glykopeptidische antibiotika
RU94014631A (ru) Производные 4-хиномиодигидропиридина, смесь их изомеров или отдельные изомеры и их соли
ES2054927T3 (es) Antibioticos glicosidicos bu-3608 d y bu-3608 e.
AU665648B2 (en) Azacycloalkane derivatives
AU2873692A (en) Nitroxyalkylamide derivatives
FI931794L (fi) Monokvaternaera 2,16-bispiperidinylandrostanderivat
KR950700297A (ko) 5-HT3-수용체 길항제로서의 2,6-메타노-2H-퀴놀리진 유도체(2,6-Methano-2H-quinolizin derivative as 5-HT3-receptor antagonist)
ES2116399T3 (es) Derivados tiazolicos de alcoxiacrilatos con una actividad fungicida.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties